-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LFjin0Py23pnAYS1xsbyqprDV1tyCKgsIpSCYQYGumvxM5bM/GptOVgeFsHwbZXn Ec+QlfC7f0wFTrgwPyRlQA== 0001181431-05-005535.txt : 20050128 0001181431-05-005535.hdr.sgml : 20050128 20050128184352 ACCESSION NUMBER: 0001181431-05-005535 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041115 FILED AS OF DATE: 20050128 DATE AS OF CHANGE: 20050128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOF PARTNERS LLC CENTRAL INDEX KEY: 0001280952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 05559651 MAIL ADDRESS: STREET 1: 126 E 56TH ST 28TH FL CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALE JAMES C CENTRAL INDEX KEY: 0001184312 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 05559650 BUSINESS ADDRESS: BUSINESS PHONE: 2124193096 MAIL ADDRESS: STREET 1: C/O SANDERS MORRIS HARRIS INC STREET 2: 126 E. 56TH ST 24TH FL CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 211 SOMERVILLE ROAD STREET 2: ROUTE 202 NORTH CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 9084702800 MAIL ADDRESS: STREET 1: 211 SOMERVILLE ROAD STREET 2: ROUTE 202 NORTH CITY: BEDMINSTER STATE: NJ ZIP: 07921 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANDERS MORRIS HARRIS INC/FA CENTRAL INDEX KEY: 0001053994 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 05559649 BUSINESS ADDRESS: STREET 1: 3100 CHASE TOWER CITY: HOUSTON STATE: TX ZIP: 77002 BUSINESS PHONE: 7132504222 MAIL ADDRESS: STREET 1: 3100 CHASE TOWER CITY: HOUSTON STATE: TX ZIP: 77002 FORMER NAME: FORMER CONFORMED NAME: SANDERS MORRIS MUNDY INC /FA DATE OF NAME CHANGE: 19980129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIFE SCIENCES OPPORTUNITIES FUND II LP CENTRAL INDEX KEY: 0001269415 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 05559652 BUSINESS ADDRESS: STREET 1: 126 EAST 56TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-419-3900 MAIL ADDRESS: STREET 1: 126 E 56TH STREET STREET 2: 28TH FL CITY: NEW YORK STATE: NY ZIP: 10022 3 1 rrd66503.xml X0202 3 2004-11-15 0 0000810084 BIOJECT MEDICAL TECHNOLOGIES INC BJCT 0001269415 LIFE SCIENCES OPPORTUNITIES FUND II LP 126 EAST 56TH STREET, 24TH FLOOR NEW YORK NY 10022 0 0 1 0 0001280952 LOF PARTNERS LLC 126 EAST 56TH STREET, 24TH FLOOR NEW YORK NY 10022 0 0 0 1 See general remarks 0001184312 GALE JAMES C 126 EAST 56TH STREET, 24TH FLOOR NEW YORK NY 10022 0 0 0 1 See General Remarks 0001053994 SANDERS MORRIS HARRIS INC/FA 600 TRAVIS, SUITE 3100 HOUSTON TX 77002 0 0 0 1 See General Remarks Series D Convertible Preferred Stock 1.15 2004-11-15 Common Stock 316884 D Series D Convertible Preferred Stock 1.15 2004-11-15 Common Stock 1770073 D Stock Purchase Warrants (Right to Buy) 1.15 2004-11-15 2008-11-15 Common Stock 95065 D Stock Purchase Warrants (Right to Buy) 1.15 2004-11-15 2008-11-15 Common Stock 531022 D Immediately 1-for-1; subject to adjustment These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by LOF Partners, LLC, the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer and manager of LOF Partners, LLC, and Sanders Morris Harris Inc., the controlling member of LOF Partners, LLC. LOF Partners, LLC, Sanders Morris Harris Inc., and James C. Gale disclaim beneficial owernship of the reported securities except to the extent of their pecuniary interest therein. These securities are owned directly by Life Sciences Opportunities Fund II (Institutional), L.P. and indirectly by LOF Partners, LLC, the general partner of Life Sciences Opportunities Fund II (Institutional), L.P., James C. Gale, the chief investment officer and manager of LOF Partners, LLC, and Sanders Morris Harris Inc., the controlling member of LOF Partners, LLC. LOF Partners, LLC, Sanders Morris Harris Inc., and James C. Gale disclaim beneficial owernship of the reported securities except to the extent of their pecuniary interest therein. No expiration date This is a joint filing by Life Sciences Opportunities Fund (Institutional)II, L.P., Life Sciences Opportunitites Fund II, L.P., LOF Partners, LLC, Sanders Morris Harris Inc., and James C. Gale. Life Sciences Opportunities Fund II, L.P. is the designated filer for Life Sciences Opportunitites Fund II (Institutional), L.P., LOF Partners, LLC, Sanders Morris Harris Inc., and James C. Gale. The address of each filer is the same as the designated filer except Sanders Morris Harris Inc., which is 600 Travis, Suite 3100, Houston, Texas 77002. See notes 3 and 4 above. James C. Gale, Manager of LOF Partners, LLC, general partner of Life Sciences Opportunities Fund (Institutional) II, L.P. and Life Sciences Oppotunities Fund II, L.P. 2005-01-28 James C. Gale, Manager of LOF Partners, LLC 2005-01-28 James C. Gale, Managing Director of Sanders Morris Harris Inc. 2005-01-28 James C. Gale 2005-01-28 -----END PRIVACY-ENHANCED MESSAGE-----